AstraZeneca PLC (AZN) Financials

$74.22

north_east
$0.71 (0.97%)
Day's range
$73.54
Day's range
$74.5
$60B$60B$50B$50B$40B$40B$30B$30B$20B$20B$10B$10B$0$0Earning2018201820192019202020202021202120222022202320232024202430%30%25%25%20%20%15%15%10%10%5%5%0%0%Profit Margin
Profit Margin
Revenue
Earnings

AZN Income statement / Annual

Last year (2024), AstraZeneca PLC's total revenue was $54.07 B, an increase of 18.03% from the previous year. In 2024, AstraZeneca PLC's net income was $7.04 B. See AstraZeneca PLC,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $54.07 B $45.81 B $44.35 B $37.42 B $26.62 B $24.38 B $22.09 B $22.47 B $23.00 B $24.71 B
Cost of Revenue $10.21 B $8.04 B $12.39 B $12.44 B $5.30 B $4.92 B $4.94 B $4.32 B $4.13 B $4.65 B
Gross Profit $43.87 B $37.77 B $31.96 B $24.98 B $21.32 B $19.46 B $17.15 B $18.15 B $18.88 B $20.06 B
Gross Profit Ratio 0.81 0.82 0.72 0.67 0.8 0.8 0.78 0.81 0.82 0.81
Research and Development Expenses $13.58 B $10.94 B $9.76 B $9.74 B $5.99 B $5.96 B $5.93 B $5.76 B $5.89 B $6.00 B
General & Administrative Expenses $19.98 B $19.22 B $0.00 $0.00 $0.00 $11.68 B $0.00 $10.23 B $9.41 B $11.11 B
Selling & Marketing Expenses $555.00 M $539.00 M $18.96 B $15.68 B $11.69 B $11.85 B $10.36 B $10.54 B $9.74 B $11.45 B
Selling, General & Administrative Expenses $20.53 B $18.03 B $18.96 B $15.68 B $11.69 B $11.85 B $10.36 B $10.54 B $9.74 B $11.45 B
Other Expenses -$252.00 M $618.00 M -$514.00 M -$1.49 B -$1.53 B -$1.54 B -$650.00 M -$10.44 B -$9.74 B -$11.63 B
Operating Expenses $33.86 B $29.58 B $28.20 B $23.92 B $16.16 B $16.27 B $13.77 B $14.47 B $13.97 B $15.95 B
Cost And Expenses $44.07 B $37.62 B $40.59 B $36.36 B $21.46 B $21.19 B $18.70 B $18.79 B $18.10 B $20.59 B
Interest Income $458.00 M $291.00 M $95.00 M $43.00 M $87.00 M $172.00 M $138.00 M $113.00 M $67.00 M $46.00 M
Interest Expense $1.74 B $1.59 B $1.35 B $1.30 B $1.31 B $1.43 B $1.42 B $1.51 B $1.38 B $1.08 B
Depreciation & Amortization $6.69 B $5.39 B $5.25 B $4.10 B $2.90 B $3.76 B $3.75 B $3.04 B $2.36 B $2.85 B
EBITDA $17.12 B $13.42 B $9.09 B $5.11 B $8.08 B $6.71 B $7.11 B $6.62 B $7.28 B $6.96 B
EBITDA Ratio 0.32 0.29 0.21 0.2 0.31 0.29 0.32 0.3 0.32 0.28
Operating Income Ratio 0.18 0.18 0.08 0.03 0.19 0.12 0.15 0.16 0.21 0.17
Total Other Income/Expenses Net -$1.31 B -$1.29 B -$1.26 B -$1.32 B -$1.25 B -$1.38 B -$1.39 B -$1.45 B -$1.35 B -$1.05 B
Income Before Tax $8.69 B $6.90 B $2.50 B -$265.00 M $3.92 B $1.55 B $1.99 B $2.23 B $3.55 B $3.07 B
Income Before Tax Ratio 0.16 0.15 0.06 -0.01 0.15 0.06 0.09 0.1 0.15 0.12
Income Tax Expense $1.65 B $938.00 M -$792.00 M -$380.00 M $772.00 M $321.00 M -$57.00 M -$641.00 M $146.00 M $243.00 M
Net Income $7.04 B $5.96 B $3.29 B $112.00 M $3.20 B $1.34 B $2.16 B $3.00 B $3.50 B $2.83 B
Net Income Ratio 0.13 0.13 0.07 0 0.12 0.05 0.1 0.13 0.15 0.11
EPS 2.27 1.92 2.12 0.08 2.44 1.03 1.7 2.37 2.77 2.23
EPS Diluted 3 1.91 2.11 0.08 2.44 1.03 1.7 2.37 2.76 2.23
Weighted Average Shares Out $3.10 B $3.10 B $1.55 B $1.42 B $1.31 B $1.30 B $1.27 B $1.27 B $1.27 B $1.26 B
Weighted Average Shares Out Diluted $2.34 B $3.12 B $1.56 B $1.43 B $1.31 B $1.30 B $1.27 B $1.27 B $1.27 B $1.27 B
Link